Skip to main content
. Author manuscript; available in PMC: 2022 Oct 30.
Published in final edited form as: J Int Neuropsychol Soc. 2020 Nov 9;27(4):365–381. doi: 10.1017/S1355617720001022

Table 1.

Overall effect of vascular risk factors on global neurocognitive impairment

Variable I2 (%) k # of effect sizes OR log(OR) p 95% CI df

Unadjusted intercept 59.28 11 26 2.059** 0.722 .009 [1.288–3.287] 5.65
Adjusted intercept - 9 24 2.136* 0.759 .017 [1.351–3.989] 2.30
AIDS (proportion) - - - 2.239 0.806 .611 [0.005–1009.59] 1.88
Nadir CD4 (cells/microliter) - - - 1.008 0.008 .335 [0.984–1.033] 2.58
HIV duration (mean/median) - - - 0.971 −0.029 .669 [0.005–1009.59] 2.51

Note: The unadjusted intercept value is the overall effect size. Adjusted intercept refers to overall effect size after accounting for listed covariates. Models with degrees of freedom <4 are not trustworthy. All models were run separately and estimated using robust variance estimation meta-analysis. Abbreviations: k = number of outcomes included in the categoryOR = odds ratio; CI = confidence interval of the OR; df = degree of freedom; AIDS = acquired immune-deficiency syndrome; HIV duration = human immunodeficiency virus years since diagnosis.

**

p < .01.

*

p < .05.